IMI - Interventions Myopia Institute: Interventions for Controlling Myopia Onset and Progression Report
Myopia has been predicted to affect approximately 50% of the world's population based on trending myopia prevalence figures. Critical to minimizing the associated adverse visual consequences of complicating ocular pathologies are interventions to prevent or delay the onset of myopia, slow its p...
Uložené v:
| Vydané v: | Investigative ophthalmology & visual science Ročník 60; číslo 3; s. M106 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
28.02.2019
|
| ISSN: | 1552-5783, 1552-5783 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Myopia has been predicted to affect approximately 50% of the world's population based on trending myopia prevalence figures. Critical to minimizing the associated adverse visual consequences of complicating ocular pathologies are interventions to prevent or delay the onset of myopia, slow its progression, and to address the problem of mechanical instability of highly myopic eyes. Although treatment approaches are growing in number, evidence of treatment efficacy is variable. This article reviews research behind such interventions under four categories: optical, pharmacological, environmental (behavioral), and surgical. In summarizing the evidence of efficacy, results from randomized controlled trials have been given most weight, although such data are very limited for some treatments. The overall conclusion of this review is that there are multiple avenues for intervention worthy of exploration in all categories, although in the case of optical, pharmacological, and behavioral interventions for preventing or slowing progression of myopia, treatment efficacy at an individual level appears quite variable, with no one treatment being 100% effective in all patients. Further research is critical to understanding the factors underlying such variability and underlying mechanisms, to guide recommendations for combined treatments. There is also room for research into novel treatment options. |
|---|---|
| AbstractList | Myopia has been predicted to affect approximately 50% of the world's population based on trending myopia prevalence figures. Critical to minimizing the associated adverse visual consequences of complicating ocular pathologies are interventions to prevent or delay the onset of myopia, slow its progression, and to address the problem of mechanical instability of highly myopic eyes. Although treatment approaches are growing in number, evidence of treatment efficacy is variable. This article reviews research behind such interventions under four categories: optical, pharmacological, environmental (behavioral), and surgical. In summarizing the evidence of efficacy, results from randomized controlled trials have been given most weight, although such data are very limited for some treatments. The overall conclusion of this review is that there are multiple avenues for intervention worthy of exploration in all categories, although in the case of optical, pharmacological, and behavioral interventions for preventing or slowing progression of myopia, treatment efficacy at an individual level appears quite variable, with no one treatment being 100% effective in all patients. Further research is critical to understanding the factors underlying such variability and underlying mechanisms, to guide recommendations for combined treatments. There is also room for research into novel treatment options. Myopia has been predicted to affect approximately 50% of the world's population based on trending myopia prevalence figures. Critical to minimizing the associated adverse visual consequences of complicating ocular pathologies are interventions to prevent or delay the onset of myopia, slow its progression, and to address the problem of mechanical instability of highly myopic eyes. Although treatment approaches are growing in number, evidence of treatment efficacy is variable. This article reviews research behind such interventions under four categories: optical, pharmacological, environmental (behavioral), and surgical. In summarizing the evidence of efficacy, results from randomized controlled trials have been given most weight, although such data are very limited for some treatments. The overall conclusion of this review is that there are multiple avenues for intervention worthy of exploration in all categories, although in the case of optical, pharmacological, and behavioral interventions for preventing or slowing progression of myopia, treatment efficacy at an individual level appears quite variable, with no one treatment being 100% effective in all patients. Further research is critical to understanding the factors underlying such variability and underlying mechanisms, to guide recommendations for combined treatments. There is also room for research into novel treatment options.Myopia has been predicted to affect approximately 50% of the world's population based on trending myopia prevalence figures. Critical to minimizing the associated adverse visual consequences of complicating ocular pathologies are interventions to prevent or delay the onset of myopia, slow its progression, and to address the problem of mechanical instability of highly myopic eyes. Although treatment approaches are growing in number, evidence of treatment efficacy is variable. This article reviews research behind such interventions under four categories: optical, pharmacological, environmental (behavioral), and surgical. In summarizing the evidence of efficacy, results from randomized controlled trials have been given most weight, although such data are very limited for some treatments. The overall conclusion of this review is that there are multiple avenues for intervention worthy of exploration in all categories, although in the case of optical, pharmacological, and behavioral interventions for preventing or slowing progression of myopia, treatment efficacy at an individual level appears quite variable, with no one treatment being 100% effective in all patients. Further research is critical to understanding the factors underlying such variability and underlying mechanisms, to guide recommendations for combined treatments. There is also room for research into novel treatment options. |
| Author | Wildsoet, Christine F Polling, Jan Roelof Trier, Klaus Sankaridurg, Padmaja Saw, Seang-Mei Cho, Pauline Read, Scott Wolffsohn, James S Walline, Jeffrey J Guggenheim, Jeremy A Chia, Audrey Wu, Pei-Chang |
| Author_xml | – sequence: 1 givenname: Christine F surname: Wildsoet fullname: Wildsoet, Christine F organization: Berkeley Myopia Research Group, School of Optometry and Vision Science Program, University of California Berkeley, Berkeley, California, United States – sequence: 2 givenname: Audrey surname: Chia fullname: Chia, Audrey organization: Singapore Eye Research Institute and Singapore National Eye Center, Singapore – sequence: 3 givenname: Pauline surname: Cho fullname: Cho, Pauline organization: School of Optometry, The Hong Kong Polytechnic University, Hong Kong – sequence: 4 givenname: Jeremy A surname: Guggenheim fullname: Guggenheim, Jeremy A organization: School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom – sequence: 5 givenname: Jan Roelof surname: Polling fullname: Polling, Jan Roelof organization: HU University of Applied Sciences, Optometry and Orthoptics, Utrecht, The Netherlands – sequence: 6 givenname: Scott surname: Read fullname: Read, Scott organization: School of Optometry and Vision Science and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia – sequence: 7 givenname: Padmaja surname: Sankaridurg fullname: Sankaridurg, Padmaja organization: Brien Holden Vision Institute and School of Optometry and Vision Science, University of New South Wales, Sydney, Australia – sequence: 8 givenname: Seang-Mei surname: Saw fullname: Saw, Seang-Mei organization: Saw Swee Hock School of Public Health, National University of Singapore, Singapore – sequence: 9 givenname: Klaus surname: Trier fullname: Trier, Klaus organization: Trier Research Laboratories, Hellerup, Denmark – sequence: 10 givenname: Jeffrey J surname: Walline fullname: Walline, Jeffrey J organization: The Ohio State University College of Optometry, Columbus, Ohio, United States – sequence: 11 givenname: Pei-Chang surname: Wu fullname: Wu, Pei-Chang organization: Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan – sequence: 12 givenname: James S surname: Wolffsohn fullname: Wolffsohn, James S organization: Ophthalmic Research Group, Aston University, Birmingham, United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30817829$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkE1LAzEYhINU7IcevcoevWzNm-w2WW9S_FhoqYiel7R5U1a2yZpkC_33rtiCeJph5mEOMyYD6ywScg10CjATd7XbhynIlOVFLs_ICPKcpbmQfPDHD8k4hE9KGQCjF2TIqQQhWTEi23JZJmlS2oh-jzbWzoZkeXBtrfowxDp2Ee__9cb5ZO5s9K5pars98SsbMCbK6uTVu63HEHo6ecPW-XhJzo1qAl4ddUI-nh7f5y_pYvVczh8WaQtsFtMMGUcOVK8LYaimILKM5cJANpPSFEYoWYChRuEGtOYKhFAbrQv5E7MC-YTc_u623n11GGK1q8MGm0ZZdF2oGEiRc9rv9ejNEe3WO9RV6-ud8ofqdA7_BvaFaWs |
| ContentType | Journal Article |
| DBID | NPM 7X8 |
| DOI | 10.1167/iovs.18-25958 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1552-5783 |
| ExternalDocumentID | 30817829 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- 18M 2WC 34G 39C 5GY 5RE ACGFO ACNCT ADBBV AENEX AFOSN ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P GROUPED_DOAJ GX1 N9A NPM OK1 P2P RPM SJN TR2 TRV W8F WH7 WOQ WOW 7X8 |
| ID | FETCH-LOGICAL-p126t-4e23e310db97f0d01744257f14688f9f7a891f0faec1dd3a177acdd98891f29e3 |
| ISSN | 1552-5783 |
| IngestDate | Fri Sep 05 12:44:54 EDT 2025 Thu Apr 03 07:07:53 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p126t-4e23e310db97f0d01744257f14688f9f7a891f0faec1dd3a177acdd98891f29e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 30817829 |
| PQID | 2187530146 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2187530146 pubmed_primary_30817829 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-02-28 |
| PublicationDateYYYYMMDD | 2019-02-28 |
| PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-28 day: 28 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Investigative ophthalmology & visual science |
| PublicationTitleAlternate | Invest Ophthalmol Vis Sci |
| PublicationYear | 2019 |
| References | 31022298 - Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1768 |
| References_xml | – reference: 31022298 - Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1768 |
| SSID | ssj0021120 |
| Score | 2.6785715 |
| SecondaryResourceType | review_article |
| Snippet | Myopia has been predicted to affect approximately 50% of the world's population based on trending myopia prevalence figures. Critical to minimizing the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | M106 |
| Title | IMI - Interventions Myopia Institute: Interventions for Controlling Myopia Onset and Progression Report |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30817829 https://www.proquest.com/docview/2187530146 |
| Volume | 60 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1552-5783 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021120 issn: 1552-5783 databaseCode: DOA dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lBSEuiDflUS0SPUUufmZ3uUWlAaEk5ZBKuVm2dzeJVGwTP9T-LP4hs9517KAilQMXK5rYcbTzaXZmZ-YbhD44DpewDaiCpzixVMrRivxIWBL20oDSIHbjhl1_SuZzulyy74PBr7YXpr4iaUqvr1n-X1UNMlC2ap39B3XvfhQE8BmUDldQO1zvpHiwRkNLn_SZWsZiOLvJ8k3UVQaoc4D9O1S14ZkuW28a1M0TF2khyrajYKVrZlPjtff92h5dRy2GWb4u19HVD83vpMBVb4qqbb_ssAQmiReZTodolgPl83ZjmNe6kndc8a246aRZW9LYqwn4Uq1gRdZCD4f-JraqTWbcP9NQbVS7HnFjhgMIkYkecXMqbpEZ261nERiMej1DPHMaIoNbdoiRylFvsro4dQA4AdPM8ftM3POLcHI5nYaL8-XixJvkPy01pkyl80-8zxoyB-ieSwLG2ijexPiOZgLd_dmW1nVEPu698-8BTePYLB6jRyYiwWONpCdoINKn6MHM1Fw8QysAFLbwHlywhgfeAerTH98DnHAPTu39DZwwwAn34IQ1nJ6jy8n54uyrZcZzWLnjjkrLF646Qbd5zIi0OZh2X20AUjXzUckkiShzpC0jkTice5FDSJRwzqgSu0x4L9BhmqXiFcK2KzwwC1SAd-zbPqcskVzE1JNgLsCWHKH37WqFYP5UTitKRVYVIXioEHArBqQj9FIvY5hrnpbQA3cXHGD2-g5Pv0EPOyC-RYflthLv0P2kLjfF9hgdkCU9bjT9G5eRio0 |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IMI+-+Interventions+Myopia+Institute%3A+Interventions+for+Controlling+Myopia+Onset+and+Progression+Report&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Wildsoet%2C+Christine+F&rft.au=Chia%2C+Audrey&rft.au=Cho%2C+Pauline&rft.au=Guggenheim%2C+Jeremy+A&rft.date=2019-02-28&rft.issn=1552-5783&rft.eissn=1552-5783&rft.volume=60&rft.issue=3&rft.spage=M106&rft_id=info:doi/10.1167%2Fiovs.18-25958&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon |